Syed Nabeel Zafar

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Clayton Thomas Marcinak · 7 shared papers, 2023–2026 · strength 1.77
   • Paper Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus-Based Con… DOI 10.1002/jso.70362↗
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
2. Muhammad Maisam Ali · 5 shared papers, 2026 · strength 1.42
   • Paper Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus-Based Con… DOI 10.1002/jso.70362↗
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
3. Noelle K. LoConte · 6 shared papers, 2022–2026 · strength 1.36
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
   • Paper ASO Visual Abstract: Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pa… DOI 10.1245/s10434-026-20507-5↗
   • Paper Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer. DOI 10.1200/cci-24-00265↗
4. Benjamin A. Y. Cher · 4 shared papers, 2026 · strength 1.20
   • Paper Assessing the Evidence for Neoadjuvant Chemotherapy in Patients with Resectable Pancreatic Adenocarcinoma Using the Rob… DOI 10.1245/s10434-026-19443-1↗
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
5. Sharon Marie Weber · 5 shared papers, 2022–2026 · strength 1.11
   • Paper Assessing the Evidence for Neoadjuvant Chemotherapy in Patients with Resectable Pancreatic Adenocarcinoma Using the Rob… DOI 10.1245/s10434-026-19443-1↗
   • Paper Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer. DOI 10.1200/cci-24-00265↗
   • Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
6. kaleem sohail Ahmed · 4 shared papers, 2024–2026 · strength 0.98
   • Paper Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus-Based Con… DOI 10.1002/jso.70362↗
   • Paper Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer. DOI 10.1200/cci-24-00265↗
   • Paper Morbidity and Mortality Following Surgery for Pancreatic Cancer in Low- and Middle-Income Countries: A Systematic Revie… DOI 10.1002/jso.27946↗
7. Daniel Erik Abbott · 4 shared papers, 2024–2025 · strength 0.76
   • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
   • Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
   • Paper Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal … DOI 10.1245/s10434-023-14347-w↗
8. David A. Kooby · 3 shared papers, 2023–2025 · strength 0.54
   • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
   • Paper Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy. DOI 10.1002/jso.27287↗
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
9. Alexander A. Parikh · 3 shared papers, 2023–2025 · strength 0.54
   • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
   • Paper Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy. DOI 10.1002/jso.27287↗
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
10. Shishir Kumar Maithel · 3 shared papers, 2023–2025 · strength 0.54
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy. DOI 10.1002/jso.27287↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
11. Jeremy D. Kratz · 2 shared papers, 2025–2026 · strength 0.49
    • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
    • Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
12. Andrea M. Schiefelbein · 2 shared papers, 2022–2026 · strength 0.40
    • Paper Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer. DOI 10.1200/cci-24-00265↗
    • Paper Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Surv… PMID 35857681↗
13. Erin M. Dickey · 2 shared papers, 2024–2025 · strength 0.37
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
14. Caitlin A. Hester · 2 shared papers, 2024–2025 · strength 0.37
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
15. Jashodeep Datta · 2 shared papers, 2024–2025 · strength 0.37
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
16. Mary P Martos · 2 shared papers, 2024–2025 · strength 0.37
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
17. Nipun B. Merchant · 2 shared papers, 2024–2025 · strength 0.37
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
18. Alexandra W. Acher · 1 shared paper, 2026 · strength 0.29
    • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
19. Patrick Beard Schwartz · 1 shared paper, 2025 · strength 0.25
    • Paper Morbidity and Mortality Following Surgery for Pancreatic Cancer in Low- and Middle-Income Countries: A Systematic Revie… DOI 10.1002/jso.27946↗
20. Mustafa Ali Khan · 1 shared paper, 2025 · strength 0.25
    • Paper Morbidity and Mortality Following Surgery for Pancreatic Cancer in Low- and Middle-Income Countries: A Systematic Revie… DOI 10.1002/jso.27946↗
21. Syed Ameen Ahmad · 1 shared paper, 2025 · strength 0.21
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
22. Kawther Abdilleh · 1 shared paper, 2025 · strength 0.21
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
23. Peter J. Hosein · 1 shared paper, 2025 · strength 0.21
    • Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
24. Michael Frederick Bassetti · 1 shared paper, 2025 · strength 0.20
    • Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗
25. Sean M. Ronnekleiv‐Kelly · 1 shared paper, 2025 · strength 0.20
    • Paper Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patien… DOI 10.1016/j.prro.2025.01.011↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.